EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Pharmacomechanical thrombectomy of iliofemoral deep vein thrombosis is associated with a low incidence of post‐thrombotic syndrome and perioperative complications

Pharmakomechanische Thrombektomie bei iliofemoraler tiefer Venenthrombose ist mit einer niedrigen Inzidenz des postthrombotischen Syndroms und perioperativer Komplikationen assoziiert

Theresa A Larkin iD, Raeed Deen iD, Taraneh Amirnezami, Alisa Shvartsbart, Laurencia Villalba

ANZ Journal of Surgery · 2024-03 · 94 (3) · 438-444

DOI: 10.1111/ans.18795 ↗

Auf einen Blick

Bei 60 Patient:innen mit akuter oder subakuter iliofemoraler tiefer Venenthrombose zeigte ein Ein-Sitzungs-Ansatz mit PMT, venösen Stents und Risikominimierung eine niedrige PTS-Rate.

Fragestellung

Welchen Einfluss haben eine einmalige pharmakomechanische Thrombektomie, dedizierte venöse Stents und Risikominimierungsmaßnahmen auf die PTS-Rate bei IFDVT?

Methode

Beobachtungsstudie; Patient:innen mit akuter oder subakuter IFDVT wurden 2015–2022 nach demselben Protokoll behandelt. Erfasst wurden prozedurale Erfolgsrate, Komplikationen, Stent-Patenz und PTS.

Ergebnisse

60 Patient:innen (58 ± 19 Jahre; 65 % Männer). Erfolgsrate 93 %; 7 % mit Komplikationen ohne Langzeitfolgen oder Mortalität. Bei median 48 Monaten (n = 32) hatten 3 Patient:innen (9 %) PTS-Symptome.

Schlussfolgerung der Autor:innen

Ein Ein-Sitzungs-Ansatz mit PMT, dedizierten venösen Stents und Risikominimierung erreichte hohe Erfolgsraten, sehr gute Langzeit-Patenz und eine niedrige PTS-Inzidenz ohne Sicherheitsnachteile.

Kernaussagen

  • Prozedurale Erfolgsrate 93 %
  • Nach median 48 Monaten: 9 % mit PTS-Symptomen
  • 7 % Komplikationen ohne Langzeitfolgen oder Mortalität

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Journal article in ANZ Journal of Surgery, published online on 2023-11-27. Written by Theresa A Larkin and 4 co-authors. Institution: Graduate School of Medicine, University of Wollongong, Wollongong, New South Wales, Australia. Major MEDLINE topics: Postthrombotic Syndrome, Venous Thrombosis. Cited 2 times so far (Crossref); 22 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

Auf einen BlickAbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Iliofemoral deep venous thrombosis (IFDVT) is associated with an incidence of post‐thrombotic syndrome (PTS) of up to 50%. PTS is associated with high morbidity, impaired quality of life and a significant economic burden. The aim of the current study was to assess the impact of a single session pharmacomechanical thrombectomy (PMT), dedicated venous stents and a risk mitigation protocol on the rate of PTS.

Methods

Between 2015 and 2022, patients presenting with acute or subacute IFDVT treated with the same protocol of single session PMT, dedicated venous stents, and risk‐mitigation measures were included. Procedural success rate, complications, stent patency and incidence of PTS were determined.

Results

Of 60 patients (58 ± 19 years; 65% male), the procedural success rate was 93%, with 7% of patients experiencing complications but no long‐term sequelae or mortality. Most ( n = 52; 87%) patients were stented, including 46% across the inguinal ligament. At 3 months post‐procedure, primary, assisted primary and secondary stent patency rates were 89%, 93% and 98%, respectively, with no loss of patency or re‐interventions after that. At latest follow‐up of a median 48 months ( n = 32), stent patency rate was 97%, with only three patients (9%) experiencing symptoms of PTS.

Conclusion

Single session PMT, dedicated venous stents and a risk‐mitigation protocol results in high success rate, excellent long‐term stent patency and low incidence of PTS without compromising safety. These results support early intervention for iliofemoral DVT.

Subjects

MeSH terms (MEDLINE)

Postthrombotic SyndromeVenous ThrombosisHumansMaleFemaleThrombolytic TherapyIncidenceQuality of LifeTreatment OutcomeIliac VeinFemoral VeinVascular PatencyThrombectomyStentsRetrospective Studies

Author keywords

AngioJetcatheter-directed lysisiliofemoral DVTpost-thrombotic syndromevenous stents

Authors and institutions

  • Graduate School of Medicine, University of Wollongong, Wollongong, New South Wales, Australia.
  • The Wollongong Hospital, Illawarra Shoalhaven Local Health District, Wollongong, New South Wales, Australia.

ORCID profiles: Theresa A Larkin, Raeed Deen

Cite

APA

Larkin, T. A., Deen, R., Amirnezami, T., Shvartsbart, A., & Villalba, L. (2024). Pharmacomechanical thrombectomy of iliofemoral deep vein thrombosis is associated with a low incidence of post‐thrombotic syndrome and perioperative complications. ANZ Journal of Surgery, 94(3), 438-444. https://doi.org/10.1111/ans.18795

Vancouver

Larkin TA, Deen R, Amirnezami T, Shvartsbart A, Villalba L. Pharmacomechanical thrombectomy of iliofemoral deep vein thrombosis is associated with a low incidence of post‐thrombotic syndrome and perioperative complications. ANZ Journal of Surgery. 2024;94(3):438-444. doi:10.1111/ans.18795

BibTeX
@article{Larkin2024,
  author = {Larkin, Theresa A and Deen, Raeed and Amirnezami, Taraneh and Shvartsbart, Alisa and Villalba, Laurencia},
  title = {Pharmacomechanical thrombectomy of iliofemoral deep vein thrombosis is associated with a low incidence of post‐thrombotic syndrome and perioperative complications},
  journal = {ANZ Journal of Surgery},
  year = {2024},
  volume = {94},
  number = {3},
  pages = {438--444},
  doi = {10.1111/ans.18795}
}
Start for free →